COMBINATION CHEMOTHERAPY WITH DOXORUBICIN, DACARBAZINE, AND IFOSFAMIDE IN ADVANCED ADULT SOFT-TISSUE SARCOMA

被引：30

作者：

BRAMWELL, V

QUIRT, I

WARR, D

VERMA, S

YOUNG, V

KNOWLING, M

EISENHAUER, E

机构：

[1] OTTAWA REG CANC CTR, OTTAWA, ONTARIO, CANADA

[2] CONTROL AGCY BRITISH COLUMBIA, VANCOUVER, BC, CANADA

[3] QUEENS UNIV, CANADA CLIN TRIALS GRP, NATL CANC INST, KINGSTON K7L 3N6, ONTARIO, CANADA

[4] PRINCESS MARGARET HOSP, TORONTO M4X 1K9, ONTARIO, CANADA

来源：

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1989年 / 81卷 / 19期

关键词：

D O I：

10.1093/jnci/81.19.1496

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1496 / 1499

页数：4

共 14 条

[1]

[Anonymous], 1979, WHO HDB REPORTING RE, V48

[2] RESPONSE TO IFOSFAMIDE AND MESNA - 124 PREVIOUSLY TREATED PATIENTS WITH METASTATIC OR UNRESECTABLE SARCOMA [J].

ANTMAN, KH ;

RYAN, L ;

ELIAS, A ;

SHERMAN, D ;

GRIER, HE .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) :126-131

[3] IFOSFAMIDE - PHARMACOLOGY, SAFETY AND THERAPEUTIC POTENTIAL [J].

BRADE, WP ;

HERDRICH, K ;

VARINI, M .

CANCER TREATMENT REVIEWS, 1985, 12 (01) :1-47

[4] CYCLOPHOSPHAMIDE VERSUS IFOSFAMIDE - FINAL REPORT OF A RANDOMIZED PHASE-II TRIAL IN ADULT SOFT-TISSUE SARCOMAS [J].

BRAMWELL, VHC ;

MOURIDSEN, HT ;

SANTORO, A ;

BLACKLEDGE, G ;

SOMERS, R ;

VERWEY, J ;

DOMBERNOWSKY, P ;

ONSRUD, M ;

THOMAS, D ;

SYLVESTER, R ;

VANOOSTEROM, A .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (03) :311-321

[5]

BRAMWELL VHC, 1988, CAN J SURG, V31, P390

[6]

BUESA J, 1987, 4TH P EUR C CLIN ONC, P235

[7]

ELIAS AD, 1986, CANCER TREAT REP, V70, P827

[8]

ELIAS AD, 1987, P ASCO, V6, P134

[9]

Hoefer-Janker H, 1975, Med Welt, V26, P972

[10]

LEGHA S, 1982, P AM ASSOC CANC RES, V123, P127

← 1 2 →